Host, The Precision Medicine Podcast | Molecular Product Development | Commercial Strategy I Innovation
There are more than 10 biomarkers recommended for #NSCLC on the NCCN Biomarker Compendia. In this study, 54% of pts received testing for PD-L1, EGFR, and ALK. 16% received no molecular testing at all. #precisionmedicine #precisiononcology #lungcancer #genomics #genetics #cancer #cancercare #ASCO https://lnkd.in/gegxAdrK
Thanks for highlighting this study Jerome, The study revealed that while 54% of #patients underwent testing for #PD-L1, #EGFR, and #ALK, and received #targetedtherapy if #biomarker '+', 16% did not undergo any #moleculartesting. The findings underscore the critical need for #comprehensive #biomarkertesting before #treatment initiation, emphasizing its pivotal role in #patientmanagement.
Surgical Oncology, Cancer Research, Real World Data, Genomics
4moEducational opportunity!